Figure 2.
Expression of SSTR5 in NETs. (A) Well-differentiated NET, G1. (B) SSTR5-positive staining, magnification x20. (C) Well-differentiated NET, G2 with microcalcifications. (D) SSTR5-positive staining, magnification x20. (E) Well-differentiated NET, G3. (F) Weak SSTR5-positive staining, magnification x40. (G) LCNEC. (H) Strong SSTR5-positive staining, x20 magnification. SSTR, somatostatin receptor; G, grade; NET, neuroendocrine tumor; LCNEC, large cell neuroendocrine carcinoma.
